Arkolith/Insider Trading/CGON/Form 4

Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Oct 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$260K
Net Open-Market Flow
-$260K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2025Sell(S)6K$43.99$260K0
Oct 9, 2025Option exercise(M)6K$3.72$22K6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 9, 2025Option exercise(M)6K—$02K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-237104) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML